Inflammatory response and extracorporeal circulation

Best Pract Res Clin Anaesthesiol. 2015 Jun;29(2):113-23. doi: 10.1016/j.bpa.2015.03.001. Epub 2015 Mar 27.

Abstract

Patients undergoing cardiac surgery with extracorporeal circulation (EC) frequently develop a systemic inflammatory response syndrome. Surgical trauma, ischaemia-reperfusion injury, endotoxaemia and blood contact to nonendothelial circuit compounds promote the activation of coagulation pathways, complement factors and a cellular immune response. This review discusses the multiple pathways leading to endothelial cell activation, neutrophil recruitment and production of reactive oxygen species and nitric oxide. All these factors may induce cellular damage and subsequent organ injury. Multiple organ dysfunction after cardiac surgery with EC is associated with an increased morbidity and mortality. In addition to the pathogenesis of organ dysfunction after EC, this review deals with different therapeutic interventions aiming to alleviate the inflammatory response and consequently multiple organ dysfunction after cardiac surgery.

Keywords: extracorporeal circulation; inflammation; neutrophil recruitment; systemic inflammatory response syndrome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiac Surgical Procedures / adverse effects*
  • Cardiac Surgical Procedures / trends
  • Extracorporeal Circulation / adverse effects*
  • Extracorporeal Circulation / trends
  • Glucocorticoids / administration & dosage
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Inflammation / etiology
  • Inflammation / metabolism
  • Inflammation / prevention & control
  • Inflammation Mediators / antagonists & inhibitors*
  • Inflammation Mediators / metabolism
  • Postoperative Complications / etiology*
  • Postoperative Complications / metabolism
  • Postoperative Complications / prevention & control
  • Systemic Inflammatory Response Syndrome / etiology*
  • Systemic Inflammatory Response Syndrome / metabolism
  • Systemic Inflammatory Response Syndrome / prevention & control

Substances

  • Glucocorticoids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Inflammation Mediators